Inflammatory mediators in nasal mucosa

The term **inflammatory mediators in nasal mucosa** encompasses a broad array of molecules involved in the immune response, particularly during conditions such as allergic rhinitis, chronic rhinosinusitis, and nasal polyposis. These mediators include cytokines (such as interleukins IL-3, IL-4, IL-5, IL-6, IL-8, IL-13, IL-17, IL-10, TNF-α, TGF-β1), chemokines (like CXCL1, CXCL2, CXCL5), and effector molecules like histamine, leukotrienes (LTC4, LTD4, LTE4), prostaglandins (PGD2), and platelet-activating factor[1][2][3]. They are produced by various cells (eosinophils, mast cells, basophils, neutrophils, T cells, fibroblasts) in response to allergens or infection and orchestrate processes such as vasodilation, increased vascular permeability, leukocyte recruitment, fibrosis, and tissue remodeling. Because the term refers to a class of many molecules and not a specific, single molecule or protein, it does not correspond to a specific drug target, molecular identifier, or gene product. In summary, this entry is not a specific molecular target but a descriptive category covering many different entities. To map to structured data on a canonical target, you would need to specify a particular inflammatory mediator (e.g., "Interleukin-5" or "Histamine receptor H1").

Other names

Inflammatory mediators of nasal mucosaNasal mucosal inflammatory mediatorsInflammatory pathways in nasal mucosa